Cigna Group Files 8-K for Regulation FD Disclosure

TL;DR

Cigna Group filed an 8-K for Reg FD. No major news, just compliance.

AI Summary

On March 3, 2025, The Cigna Group filed an 8-K report. The filing primarily concerns Regulation FD disclosures, indicating that the company is providing information to the public in accordance with fair disclosure rules. No specific financial transactions or material events were detailed in the provided excerpt.

Why It Matters

This filing ensures Cigna Group adheres to fair disclosure regulations, providing transparency to investors regarding public communications.

Risk Assessment

Risk Level: low — The filing is a routine regulatory disclosure and does not indicate any immediate financial or operational risks.

Key Players & Entities

• The Cigna Group (company) — Registrant
• March 3, 2025 (date) — Date of Report
• Delaware (jurisdiction) — State of Incorporation
• Bloomfield, Connecticut (location) — Principal Executive Offices

FAQ

From the Filing

0001140361-25-006753.txt : 20250303 0001140361-25-006753.hdr.sgml : 20250303 20250303161535 ACCESSION NUMBER: 0001140361-25-006753 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250303 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20250303 DATE AS OF CHANGE: 20250303 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Group CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 25698118 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20181221 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 8-K 1 ef20044506_8k.htm 8-K false 0001739940 NYSE 0001739940 2025-03-03 2025-03-03 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 3, 2025 The Cigna Group (Exact name of registrant as specified in its charter) Delaware 001-38769 82-4991898 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 900 Cottage Grove Road Bloomfield , Connecticut 06002 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: ( 860 ) 226-6000 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $0.01 CI New York Stock Exchange, Inc. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 7.01 Regulation FD Disclosure.   2025 Outlook Affirmation   The Cigna Group (or “our”) officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, The Cigna Group officials expect to reaffirm projected full year 2025 consolidated adjusted income from operations on a per share basis of at least $29.50 per share.   The Cigna Group previously discussed its full year 2025 outlook in its press release and investor presentation dated January 30, 2025, and during the related investor conference call. The press release, presentation and the conference call transcript are available in the Investor Relations section of The Cigna Group’s website located at www.thecignagroup.com. Forward-looking statements in these documents and the related call speak only a